Detection of Carbapenemases From a Technologist’s Perspective

Slides:



Advertisements
Similar presentations
HODGE TEST SKILL BASED LEARNING
Advertisements

b-lattamasi Penicillinasi-cefalosporinasi-carbapenemasi
Detection of ESBLs & AmpC
Detection of b-Lactamase-Mediated Resistance
Game plan Lecture Antibiotics Antibiotic resistance Gene transfer Transformation Transduction Conjugation Lab Lab Exam Pre-lab Transformation.
Prevalence of ESBL and MBL antibiotic resistance genes in Klebsiella pneumoniae in Pretoria Academic Hospital Maningi NE, Ehlers MM, Hoosen AA, Makgothlo.
Emerging Antimicrobial Resistance in Texas The new ESBLs.
CRE Surveillance Activities
2009 CLSI M100-S19 Update Nebraska Public Health Laboratory.
Methods for detection β-lactamases Sarah Alharbi.
New Resistance in Gram Negative Rods (GNRs)
Welcome to the CDS Workshop Jeanette Pham Syd Bell Hobart 2011.
Lecture 5 Enzymatic destruction (ESBL) Enzymatic modification (erm )
WELCOME to the CDS WORKSHOP Sydney Excel Spreadsheet for Registration.
Plate 1a: Staphylococcus aureus resistant to penicillin (P0.5) only. Note the annular radius of the zone of inhibition of 9.5 mm around the cefoxitin (FOX.
Plasmid mediated Metallo-Beta- Lactamase (MBL) Plasmid mediated Hydrolyses all beta-lactam (except aztreonam) Inhibited by EDTA Binds zinc (Zn 2+ ) Pseudomonas.
CEPHALOSPORINS First used clinically in the early 1960’s. First used clinically in the early 1960’s. They have an important role in the modern treatment.
Antimicrobial Susceptibility Testing (AST)
Train-the-Trainer Interacting with your laboratory colleagues Customize this presentation with your organization’s logo, etc. 13/17/2014.
Resistance to  -lactam antibiotics within the Enterobacteriaceae Paul D. Fey, Ph. D. University of Nebraska Medical Center.
Update on ESBLS and Carbapenem Resistant Enterobacteriaceae
COL Helen Viscount, PhD, D(ABMM) LTC Steven Mahlen, PhD, D(ABMM)
Beta lactam antibiotics & Other cell wall synthesis inhibitors
12 August 2003 AmpC  -Lactamases & their detection David Livermore Health Protection Agency, Colindale, London.
Jhindler nltn MW tele #
Detection of  -lactamase- mediated resistance David Livermore Health Protection Agency, Colindale, London.
ESBL, MBL and Amp C beta lactamase detection DEPARTMENT OF MICROBIOLOGY JIPMER PUDUCHERRY.
SCACM Workshop Detection of Antibiotic Resistance in Gram-Negative Bacilli October 3, 2007 Detection and Reporting of Beta-lactam Resistance in Enterobacteriaceae.
Nebraska Public Health Laboratory 2008 CLSI M100-S18 update Paul D. Fey, Ph.D. Associate Professor/Associate Director Josh Rowland, M.T. (ASCP) State Training.
X. James Li, Ph.D. Cellex, Inc.. Topics  Homogeneous Biochemiluminescence Assays (HBA) and Its Use for Detection of Influenza Viral Neuraminidase (NA)
Antimicrobial Resistance patterns among nosocomial gram negative bacilli by E-test and disc diffusion methods in Sina and Imam Hospital.
What’s happening now ? Epidemiology of (carbapenem) resistance Neil Woodford HPA – AMRHAI - Colindale.
Hospital Acquired Pneumonia(HAP): is defined as a pneumonia which occurs after 48 hours of admission to hospital. Hospital Acquired Pneumonia(HAP): is.
Standing Up Against Antibiotic Resistance With Synergistic Approach
Supplemental testing methods
Dr. Iman M. Fawzy Clinical Pathology MD, PhD Mansoura, Egypt
Development of a Real-Time PCR (RT-PCR) Assay for Carbapenemase Producing Bacteria including Enterobacteriaceae B. Mather, P. L. White, M. Wootton, R.
ESBL, AmpC -lactamase 표준진단법
Part II High Priority Resistant Organisms. Healthcare Associated Infections NHSN Staphylococcus aureus (16%) 2.Enterococcus spp (14%) 3.Escherichia.
(Ambler class A, Bush group 2) Inhibited by CA
4/28/2017 AST.
MRSA, ESBLs and Carbapenem Resistance
Justin Jones, PharmD, BCPS Critical Care Pharmacist Sanford Medical Center, Fargo Bent or Broken? Re-evaluating the β-lactam backbone for ESBL-producing.
Cephalosporins Four Generations! Bactericidal & Time-Dependent!
Carbapenemase-Producing Carbapenem-Resistant Enterobacteriaceae
Carbapenem-Resistant Enterobacteriaceae (CRE)
Development of strategies for management of infections with carbapenem resistant bacteria Myths and Facts Dr. Bhoj R Singh Act. Head of Division of Epidemiology.
Current Status of Antimicrobial Resistance
N°XXXX Rapid detection of extended-spectrum BETA-lactamase producing Enterobacteriaceae from urine using the ESBL NDP test Patrice Nordmann, Laurent Poirel,
Amela Dedeić-Ljubović
Gram Negative Resistance Mechanisms: Running Out of Options
Standardisation – What does this mean for the CDS?
The Role of the Microbiology Laboratory in AMS programs
Cell wall inhibitor Cephalosporins Dr. Naza M. Ali Lec D
Clinico-Pathological Conference (CPC) Meet
Antibiotics sensitivity of microorganism causing nosocomial infections
D-739/181 50th ICAAC Sept , 2010 Boston
D-735/178 50th ICAAC Sept , 2010 Boston
Dr David Garner Consultant Microbiologist
Table 1: Resistance profile
Antimicrobial Resistance: from Global to Local
A simple test for the detection of KPC and metallo-β-lactamase carbapenemase- producing Pseudomonas aeruginosa isolates with the use of meropenem disks.
Clarifying CRE Reporting in NHSN
C th Interscience Conference on Antimicrobial Agents and Chemotherapy October 25-28, Washington, DC Examining Temocillin Activity in Combination.
C th Interscience Conference on Antimicrobial Agents and Chemotherapy October 25-28, Washington, USA Emergence of VIM-2 Metallo--lactamase.
Antibiotic Resistance
Phenotypic detection of extended-spectrum β-lactamase production in Enterobacteriaceae: review and bench guide  L. Drieux, F. Brossier, W. Sougakoff,
TRAINING PRESENTATION
β- Lactamase Inhibitor
Carbapenem Resistance: Defining, Detecting, and Responding
Presentation transcript:

Detection of Carbapenemases From a Technologist’s Perspective Courtney Fraser MLS (ASCP) Microbiology Supervisor ACL Laboratories

Disclosure I will discuss specific brand names in this presentation. I do not have stock in, nor receive honoraria for any commercial product mentioned in this presentation.

Introduction Automation is not available for carbapenemase confirmatory testing. Resistance mechanisms are not typically discussed in the classroom for most MLS students. Seasoned Techs currently in the field are not used to resistance in organisms and are unfamiliar with the mechanisms related to resistance. Education needed on antibiotic classifications.

Purpose of Presentation Define types of carbapenemases and understand classifications When to test How to test How to incorporate instrumentation tools

What is a Carbapenemase? First, need to understand what are the carbapenems: Ertapenem Imipenem Meropenem Doripenem Second, the suffix –ase indicates an enzyme A carbapenemase is an enzyme produced by bacteria that hydrolyze (deactivate) carbapenems

Carbapenems Large groups Meropenem All share a common β-lactam ring, β-lactamases target the β-lactam ring) differences are in ring stabilization from hydrolysis protection of ring from β-lactamase by addition of large groups blocking the substrate site Imipenem Ertapenem Large groups

Why Important? Studies have shown that rapid detection of carbapenemases have attributed to positive patient treatment outcomes. Infection Control emergency – These mechanisms can be plasma-mediated allowing for easy transmission to other organisms. Detection of these resistance mechanisms should initiate contact precautions for patients , thus reducing the spread of nosocomial related infections. Deter inappropriate antibiotic use thus prolonging the efficacy of available antibiotics

The Rise of Carbapenemases

ACL Laboratories Overview ACL Laboratories is defined as an operating management agreement between Advocate Health Care and Aurora Health Care. Two Central Labs (Rosemont, IL., West Allis, WI.) Total of 27 hospitals Rosemont

Wisconsin vs. Illinois 2011

KPC Isolates 2009 and 2011 - Chicago

Types of β-Lactamases/Carbapenemases Type A (Ambler) – KPC – 1st described 1998, endemic in NYC since 2004. Moving west. 1st isolates in Chicago area in 2/08 Type B – Metallo ß-lactamases Found in Stenotrophomonas maltophilia Enterobacteriaceae and P. aeruginosa - Reported sporadically in U.S. Watch out for NDM-1 which has spread to Europe (Sweden and England) from India Type D – Oxa-40 – Endemic in Acinetobacter baumannii in the Chicago area since 2002 Hyper AmpC producers Mutations in AmpC promoter and attenuator/promoter regions Poorly inhibited by lactam—lactamase inhibitor combinations E. coli produces AmpC (poorly) and is unlike other bacteria with AmpC the gene is not inducible No ampR regulatory gene All the above can give a positive Hodge Test! 13 13

Types of Carbapenemases Enzyme Type Ambler Class Activity Spectrum Organism(s) KPC (1-10) (plasmid) A All β-lactams Enterobacteriaceae Ps. aeruginosa SME Carbapenems and aztreonam, but not 3rd/4th Gen cephalosporins S. marcescens , not plasmid Associated. NMC–A, IMI MNC = Not metallo carbapenemase IMI = IMI hydrolyzing Β-lactamase Same as for SME Enterobacter spp. GES GES= Guiana extended spectrum (plasmid) Imipenem and 3rd/4th cephalosporins Ps. Aeruginosa and Enterobacteriaceae IMI, VIM, NDM-1 VIM = Verona Integron encoded MBL) NDM-1 = New Delhi metallo β lactamase B (metallo-β-lactamases) All β-lactams; can test susceptible to aztreonam (NDM-1 variable AZT resistance) Pseudomonas spp. Acinetobacter spp. Enterobacteriaceae OXA (Oxacillin hydrolyzing) D Weakly active against carbapenems A. baumanii, P. Aeruginosa, and rare Enterobacteriaceae S. marcescens enzyme Pediatr Infect Dis J. 2010;29(1):68-70. 

Recommendations for Screening Any Enterobacteriaceae At least one carbapenem with an increased MIC (ertapenem is most sensitive, but not specific) and at least one resistant 3rd or 4th generation cephalosporins: Ceftriaxone Ceftazidime Cefotaxime Ceftizoxime Cefepime Screen for KPC, MBL, and AmpC ESBL testing is performed by automated instrumentations.

KPC Klebsiella pneumoniae Carbapenemase 1st reported on the East Coast of the United States in the late 1990’s Currently found worldwide. Can be associated with other Enterobacteriaceae. KPC gene is plasmid-mediated which has contributed to the rapid dissemination across the globe. Hydrolyze all beta-lactam antibiotics. Can be detected by Modified Hodge Test Boronic Acid inhibition

Modified Hodge Test (MHT) Used for the detection of KPC producing isolates Carbapenem disk: meropenem – gold standard – most specific Increased MIC for imipenem seen is Proteus, Providencia, and Morganella Indentation of the inhibition zone indicates that the test strain is hydrolyzing the carbapenem. Not specific for KPC AmpC enzymes can give weak false positive results that can be accentuated by porin loss

Modified Hodge Test (MHT)

Alternative Test Rosco kit for carbapenemase detection 4 disks all on one plate: Meropenem (MRP10) Meropenem + Boronic Acid (MRPBO) *KPC Meropenem + Cloxacillin (MR+CX) *AmpC Meropenem + DPA Dipicolinic acid (MR+DP) *MBL Easier to read compared to the MHT Reduced the risk of false positives for KPC Detects true hyperproduction of AmpC by utilizing a carbapenem instead of a cephamycin

Rosco Kit

Positive for KPC

Metallo Beta-Lactamase (MBL) Uses a zinc cation for the hydrolysis of the beta-lactam ring Activity is inhibited by EDTA (similar to clavulanic acid and ESBL) Hydrolyze all beta-lactam antibiotics except aztreonam. Chromosomal presence found in Stenotrophomonas, Aeromonas, and Chryseobacterium. Clinically significant MBLs have transmitted to other bacterial pathogens.

Detection of MBL Ratio MP/MPI >8 (or 3 fold)

AmpC Chromosomal = MY SPACE bugs (Morgenella, Y. enterocolitica, Serratia, Providencia, Aeromonas, Citrobacter, Enterobacter) Inducible = Any MYSPACE or Enterobacteriaceae containing AmpC plasmid Organism may develop resistance during prolonged therapy with 3rd generation cephalosporins. Identified in organisms exhibiting the following: Resistant to cephamycins Cefoxitin Cefotetan Sensitive to Cefepime Hyperproduction = Any Enterobacteriaceae Caused by a mutation in the AmpC gene leading to permanent hyperproduction or derepression.

The AmpC gene is now found on a plasmid We can no longer predict which bacteria are AmpC positive Amp C is upregulated by treatment with β-lactam drugs Amount of enzyme produced is dependant on the selection of stable mutants with upregulated genes.

AmpC + Porin Loss = “Carbapenemase”

AmpC Many different AmpC enzymes C. freundii cluster CMY-2 Enterobacter cluster MIR-1, ACT-1 M. morganii cluster** DHA-1 H. alvei cluster ACC-1 Aeromonas cluster CMY-1 and FOX-1 Degree of carbapenemase resistance is dependant on type of AmpC in a porin deficient isolate

Detection of AmpC Hyperproducer

Education and Training In the past, technologists did not need to use antibiotic classification in everyday use. Education may be needed to help technologists understand the importance of classifications. Tools are available in automated instrumentation that can help technologists on the bench.

MicroScan Report

Vitek Observa Report

Tools in Instrumentation Custom comments/alerts can be printed on the patient report generated from the instrument. Activation of these tools can significantly increase the technologist’s awareness on when to appropriately screen for carbapenemases. Can also be used for many other difficulties in AST reporting.

Creating a MicroScan Comment

MicroScan Alert Rules

MicroScan Patient Report

How to Build a BIOART Rule

Vitek Patient Report

References Bush, Karen, Jacoby, George, Antimicrobial Agents and Chemotherapy,Minireview Updated Functional Classification of Beta-Lactamases, Mar. 2010, Vol.54, No. 3, p.969-976. Fernando, Pasteran, Tania Mendez, Melina Rapoport, Leonor Guerriero, and Alejandra Corso, Controlling False Positive Results Obtained with the Hodge…J. Clin. Microbiol. 2010, 48(4):1323 (2010). Gazin, Muriel, Fabienne Paasch, Herman Goossens and Surbhi Malhotra-Kumar, Current Trends in Culture-Based and Molecular Detection of ESBL Harboring and Carbapenem Resistant Enterobacteriaceae, J. Clin. Microbiol. 2012, 50(4). Rosco Diagnotica www.rosco.dk Siemens Microscan Biomerieux Vitek 2 Observa

THANK YOU!!! A big THANK YOU to the ACL Sensitivity Training Team!!! Your passion and dedication to AST testing has served both patients and your fellow coworkers. Questions?